Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: J Immigr Minor Health. 2011 Feb;13(1):36–41. doi: 10.1007/s10903-010-9330-z

Table 2.

Number and percent of prostate-cancer cases by category of selected clinical characteristics

Characteristic Category Number Percent
Pre-diagnostic prostate specific antigen (PSA) level (ng/ml)
<4 6 7
4 to <20 36 44
20 to <50 22 27
50 to <100 7 9
100+ 10 13
Total 81 100
Gleason grade
5 (low) 1 2
6 32 42
7 24 32
8 12 16
9 5 6
10 (high) 2 2
Total 76 100
Clinical stagea
T1 29 36
T2 26 32
T3 11 14
T4 15 18
Total 81 100
Aggressive diseaseb
Yes 60 74
No 21 26
Total 81 100
a

T1 tumor present but not palpable or detectable with imaging, T2 tumor can be palpated on examination but has not spread beyond the prostate capsule, T3 tumor has spread through the prostate capsule, T4 tumor has metastasized

b

Aggressive disease defined as Gleason grade 7–10, Stage T3–T4, or PSA >20ng/ml